I-2906
CAS No. 331963-29-2
I-2906 ( I 2906;I2906 )
Catalog No. M14114 CAS No. 331963-29-2
A novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 82 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameI-2906
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity.
-
DescriptionA novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity; shows good activity against M. tuberculosis H37Ra with MIC of 0.5 ug/ml; significantlt reduces bacterial loads of both lungs and spleen in a murine model.Bacterial Infection Preclinical
-
SynonymsI 2906;I2906
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationBacterial Infection
Chemical Information
-
CAS Number331963-29-2
-
Formula Weight443.58
-
Molecular FormulaC25H37N3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCCCCCCCCCCCC(=O)NNC(=O)C1=C(C2=CC=CC=C2N(C1=O)CC)O
-
Chemical Name3-Quinolinecarboxylic acid, 1-ethyl-1,2-dihydro-4-hydroxy-2-oxo-, 2-(1-oxotridecyl)hydrazide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lu J, et al. Pharmacology. 2010;85(6):365-71.
molnova catalog
related products
-
Salinomycin sodium
A polyether ionophore antibacterial agent that shows effects on mitochondrial ion translocation and respiration.
-
Glycol chitosan
Glycol chitosan is a chitosan derivative with hydrophilic ethylene glycol branches.
-
Cefixime
Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime.